Agenus (AGEN) Total Debt Growth (1y) (2011 - 2026)
Agenus (AGEN) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | - |
| 10 | Agenus | 230.49 Mn | 195.50 Mn | 33.74 Mn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.08% |
| Dec 31, 2025 | 34.62% |
| Sep 30, 2025 | 155.27% |
| Jun 30, 2025 | 152.31% |
| Mar 31, 2025 | 5,386.44% |
| Dec 31, 2024 | 156.86% |
| Sep 30, 2024 | 3.39% |
| Jun 30, 2024 | 0.98% |
| Mar 31, 2024 | -95.52% |
| Dec 31, 2023 | -0.76% |
| Sep 30, 2023 | 3,356.27% |
| Jun 30, 2023 | 1,929.77% |
| Mar 31, 2023 | 1,061.62% |
| Dec 31, 2022 | -3.97% |
| Sep 30, 2022 | -97.16% |
| Jun 30, 2022 | -96.69% |
| Mar 31, 2022 | -94.23% |
| Dec 31, 2021 | -31.26% |
| Sep 30, 2021 | -34.18% |
| Jun 30, 2021 | -2.75% |